Arbutus Biopharma Corporation (NASDAQ: ABUS) has announced new data from its im-Prove I Phase 2a clinical trial (AB-729-201) showing significant progress in achieving a functional cure for patients ...

Plexus Corp. attributed the decrease in net sales to market-driven inventory corrections and weaker customer demand, particularly in the Healthcare/Life Sciences and Industrial market sectors. The ...

Fluence Energy shares slid -7.1% this afternoon. Here's what you need to know about the Mid-CapUtilities - renewable company: ...

The market seems to share this optimistic view, since Alibaba has a short interest of only 3.1% (this is the percentage of ...

PTC Inc. has recently released its 10-K report, detailing its financial performance for the fiscal year ending September 30, ...

It's important to note that the termination of Capital One's Walmart program agreement, effective May 21, 2024, increased the ...

Nu Holdings Ltd. provides digital banking platform in Brazil, Mexico, Colombia, Cayman Islands, Germany, Argentina, the ...

One of the losers of today's trading session was Repligen. Shares of the Biotechnology company plunged -14.2%, and some ...

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

As a result of these announcements, the company's shares have moved 15.6% on the market, and are now trading at a price of ...

For Coinbase Global, average sales revenue over the last 4 years has been $3.99 Billion, so in the context of the Graham ...

This morning we watched Applied Materials drop -8.0% to a price of $171.06 per share. The Large-Cap Semiconductors company is ...